Effects of Thiazolidinediones on Polycystic Ovary Syndrome: a Meta-analysis of Randomized Placebo-Controlled Trials

[11] Carmina E.(2002)Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells Biol Reprod 66 190-198

[12] Diamanti-Kandarakis E.(2001)Troglitazone (Rezulin) and hepatic injury Pharmacoepidemiol Drug Saf 10 537-547

[13] Phelan N.(2000)Late-onset troglitazone-induced hepatic dysfunction Diabetes Care 23 128-129

[14] O’Connor A.(2000)Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group Dig Dis Sci 45 549-553

[15] Kyaw-Tun T.(2011)Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis Clin Endocrinol (Oxf) 74 332-339

[16] Fearnley E.J.(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-25

[17] Marquart L.(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 21 339-114

[18] Spurdle A.B.(2007)Random-effects model for meta-analysis of clinical trials: an update Contemp Clin Trials 28 105-1558

[19] Atiomo W.(2002)Quantifying heterogeneity in a meta-analysis Stat Med 21 1539-209

[20] Read A.(2011)Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study Fertil Steril 95 203-1235

[11] Carmina E.(2002)Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells Biol Reprod 66 190-198

[12] Diamanti-Kandarakis E.(2001)Troglitazone (Rezulin) and hepatic injury Pharmacoepidemiol Drug Saf 10 537-547

[13] Phelan N.(2000)Late-onset troglitazone-induced hepatic dysfunction Diabetes Care 23 128-129

[14] O’Connor A.(2000)Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group Dig Dis Sci 45 549-553

[15] Kyaw-Tun T.(2011)Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis Clin Endocrinol (Oxf) 74 332-339

[16] Fearnley E.J.(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-25

[17] Marquart L.(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 21 339-114

[18] Spurdle A.B.(2007)Random-effects model for meta-analysis of clinical trials: an update Contemp Clin Trials 28 105-1558

[19] Atiomo W.(2002)Quantifying heterogeneity in a meta-analysis Stat Med 21 1539-209

[20] Read A.(2011)Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study Fertil Steril 95 203-1235